These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24777949)

  • 1. Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions.
    Schirmer L; Srivastava R; Kalluri SR; Böttinger S; Herwerth M; Carassiti D; Srivastava B; Gempt J; Schlegel J; Kuhlmann T; Korn T; Reynolds R; Hemmer B
    Ann Neurol; 2014 Jun; 75(6):810-28. PubMed ID: 24777949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Kir4.1 and Kir5.1 inwardly rectifying potassium channels in oligodendrocytes, the myelinating cells of the CNS.
    Brasko C; Hawkins V; De La Rocha IC; Butt AM
    Brain Struct Funct; 2017 Jan; 222(1):41-59. PubMed ID: 26879293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulation of reactive changes around multiple sclerosis lesions by phosphorylated signal transducer and activator of transcription.
    Lu JQ; Power C; Blevins G; Giuliani F; Yong VW
    J Neuropathol Exp Neurol; 2013 Dec; 72(12):1135-44. PubMed ID: 24226263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced accumulation of Kir4.1 protein, but not mRNA, in a murine model of cuprizone-induced demyelination.
    Nakajima M; Kawamura T; Tokui R; Furuta K; Sugino M; Nakanishi M; Okuyama S; Furukawa Y
    Brain Res; 2013 Nov; 1537():340-9. PubMed ID: 24070676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease.
    Kraus V; Srivastava R; Kalluri SR; Seidel U; Schuelke M; Schimmel M; Rostasy K; Leiz S; Hosie S; Grummel V; Hemmer B
    Neurology; 2014 Feb; 82(6):470-3. PubMed ID: 24415573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study.
    Brickshawana A; Hinson SR; Romero MF; Lucchinetti CF; Guo Y; Buttmann M; McKeon A; Pittock SJ; Chang MH; Chen AP; Kryzer TJ; Fryer JP; Jenkins SM; Cabre P; Lennon VA
    Lancet Neurol; 2014 Aug; 13(8):795-806. PubMed ID: 25008548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease.
    Bugiani M; Postma N; Polder E; Dieleman N; Scheffer PG; Sim FJ; van der Knaap MS; Boor I
    Brain; 2013 Jan; 136(Pt 1):209-22. PubMed ID: 23365098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expressional analysis of inwardly rectifying Kir4.1 channels in Noda epileptic rat (NER).
    Harada Y; Nagao Y; Shimizu S; Serikawa T; Terada R; Fujimoto M; Okuda A; Mukai T; Sasa M; Kurachi Y; Ohno Y
    Brain Res; 2013 Jun; 1517():141-9. PubMed ID: 23603404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium channel KIR4.1 as an immune target in multiple sclerosis.
    Srivastava R; Aslam M; Kalluri SR; Schirmer L; Buck D; Tackenberg B; Rothhammer V; Chan A; Gold R; Berthele A; Bennett JL; Korn T; Hemmer B
    N Engl J Med; 2012 Jul; 367(2):115-23. PubMed ID: 22784115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of distinct galectins in multiple sclerosis lesions.
    Stancic M; van Horssen J; Thijssen VL; Gabius HJ; van der Valk P; Hoekstra D; Baron W
    Neuropathol Appl Neurobiol; 2011 Oct; 37(6):654-71. PubMed ID: 21501208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of osteopontin and alphaBeta-crystallin in the normal-appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays.
    Sinclair C; Mirakhur M; Kirk J; Farrell M; McQuaid S
    Neuropathol Appl Neurobiol; 2005 Jun; 31(3):292-303. PubMed ID: 15885066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of aquaporin 4 in human brain with inflammatory diseases.
    Aoki-Yoshino K; Uchihara T; Duyckaerts C; Nakamura A; Hauw JJ; Wakayama Y
    Acta Neuropathol; 2005 Sep; 110(3):281-8. PubMed ID: 16133546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kir4.1 expression by astrocytes and oligodendrocytes in CNS white matter: a developmental study in the rat optic nerve.
    Kalsi AS; Greenwood K; Wilkin G; Butt AM
    J Anat; 2004 Jun; 204(6):475-85. PubMed ID: 15198689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression analysis of normal appearing brain tissue in an animal model for multiple sclerosis revealed grey matter alterations, but only minor white matter changes.
    Zeis T; Kinter J; Herrero-Herranz E; Weissert R; Schaeren-Wiemers N
    J Neuroimmunol; 2008 Dec; 205(1-2):10-9. PubMed ID: 18950873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laminin-induced aggregation of the inwardly rectifying potassium channel, Kir4.1, and the water-permeable channel, AQP4, via a dystroglycan-containing complex in astrocytes.
    Guadagno E; Moukhles H
    Glia; 2004 Aug; 47(2):138-49. PubMed ID: 15185393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kir4.1 channels regulate swelling of astroglial processes in experimental spinal cord edema.
    Dibaj P; Kaiser M; Hirrlinger J; Kirchhoff F; Neusch C
    J Neurochem; 2007 Dec; 103(6):2620-8. PubMed ID: 17953658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased 14-3-3 immunoreactivity in glial elements in patients with multiple sclerosis.
    Kawamoto Y; Akiguchi I; Kovács GG; Flicker H; Budka H
    Acta Neuropathol; 2004 Feb; 107(2):137-43. PubMed ID: 14605832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
    Brück W; Popescu B; Lucchinetti CF; Markovic-Plese S; Gold R; Thal DR; Metz I
    Ann Neurol; 2012 Sep; 72(3):385-94. PubMed ID: 23034911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligodendrocyte gap junction loss and disconnection from reactive astrocytes in multiple sclerosis gray matter.
    Markoullis K; Sargiannidou I; Schiza N; Roncaroli F; Reynolds R; Kleopa KA
    J Neuropathol Exp Neurol; 2014 Sep; 73(9):865-79. PubMed ID: 25101702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.